Stay updated on Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the earlier funding-status notice and Revision: v3.4.1. The core study details and navigation remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded a general funding notice with a v3.4.1 update. Removed the 'Type 1 diabetes' topic and related items (MedlinePlus Genetics) tied to the prior v3.4.0.SummaryDifference0.2%

- Check28 days agoChange DetectedUI updates include a 'Show glossary' option and new topic labels such as 'Type 1 diabetes' and related topics (e.g., MedlinePlus Genetics), along with metadata changes reflecting revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor metadata update: Revision v3.3.4 replaces v3.3.3; no impact on study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section now lists expanded study sites across the US, Canada, and Europe, and the previous location blocks have been removed.SummaryDifference2%

- Check77 days agoChange DetectedRemoved the Type 1 Diabetes condition label and the MedlinePlus Genetics related topics section from the study page.SummaryDifference0.1%

Stay in the know with updates to Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.